A carregar...
Cost-effectiveness analysis of treating transplant-eligible multiple myeloma patients in Macedonia
PURPOSE: A decision-analytic model was developed to study the impact of induction regimens vincristine, adriamycin, dexamethasone (VAD); thalidomide, dexamethasone (TD); and bortezomib, dexamethasone (BorD), followed by autologous stem cell transplantation (ASCT) for treating multiple myeloma (MM) p...
Na minha lista:
| Publicado no: | Clinicoecon Outcomes Res |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6016005/ https://ncbi.nlm.nih.gov/pubmed/29950875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S152437 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|